• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • Rispond
    / Unipharm


    Active Ingredient
    Risperidone 1 mg, 2 mg, 3 mg, 4 mg, 1mg/ml

    Status in Israel
    RX

    Presentation and Status in Health Basket

    Presentation Basket Yarpa Pharmasoft

    Coated Tablets

    30 X 1 mg

    partial basket chart 55822 18355

    Coated Tablets

    30 X 2 mg

    partial basket chart 55823 18356

    Coated Tablets

    30 X 3 mg

    partial basket chart 55824 18357

    Coated Tablets

    30 X 4 mg

    partial basket chart 55825 18358

    Solution

    30 ml x 1mg/ml

    partial basket chart 80979 18404

    Related information


    Dosage

    The dosage must be adjusted individually, the drug can be taken with or without food.  Please refer to the license holder for further details. This medicine is not intended for children suffering from schizophrenia or mania. Behavioral disturbances can be treated in children over 5 years of age. The minimum age at which treatment with this drug can be started for other indications will be determined by the doctor. A lower dosage should be used for elderly patients, as instructed by the doctor.
    Please refer to the license holder for further details.


    Indications

    Risperidone is indicated for the management of schizophrenia and manifestation of psychotic disorders. The antipsychotic efficacy of Risperidone was established in short-term (6 to 8-weeks) controlled trials of schizophrenic inpatients. Risperidone is also effective in maintaining the clinical improvement during continuation therapy in patients who have shown an initial treatment response. Risperidone is indicated for the short-term treatment (up to 6 weeks) of persistent aggression in patients with moderate to severe Alzheimer’s dementia unresponsive to non-pharmacological approaches and when there is a risk of harm to self or others. Conduct and other disruptive disorders: Treatment of behavioral disorders expressed by impulse control disorders or self-alienated-aggressive or treatment-requiring behavioral disorders with reduced or substandard intelligence. Treatment should not be given to children under the age of 5 years. Risperidone is indicated for the treatment of mania in bipolar disorder. These episodes are characterized by symptoms such as elevated, expansive or irritable mood, inflated self-esteem, decreased need for sleep, pressured speech, racing thoughts, distractibility, or poor judgment, including disruptive or aggressive behaviors.


    Contra-Indications

    Hypersensitivity to active substance or to any of its excipients.


    Special Precautions

    Please refer to the license holder for further details.


    Side Effects

    Please refer to the license holder for further details.


    Drug interactions

    Please refer to the license holder for further details.


    Pregnancy and Lactation

    Please refer to the license holder for further details.


    Overdose

    Please refer to the license holder for further details.


    Important notes

    Please refer to the license holder for further details.

     


    Manufacturer
    Trima Israel Pharmaceutical Products Maabarot Ltd. Israel
    CLOSE